Xeris Pharmaceuticals Inc (NQ: XERS )
2.810
+0.010
(+0.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Xeris Pharmaceuticals Inc
![](https://mms.businesswire.com/media/20240822640280/en/2221707/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
Xeris to Participate in Upcoming Investor Conferences
August 22, 2024
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2024/08/14/Penny-stock-gli-insider-muovono-il-merca.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/08/13/Penny-stock-gli-insider-muovono-il-merca.jpeg?width=1200&height=800&fit=crop)
Xeris Biopharma And 2 Other Penny Stocks Insiders Are Buying
August 13, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240808523637/en/2210223/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
Xeris Biopharma Reports Second Quarter 2024 Financial Results
August 08, 2024
Via Business Wire
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Xeris Biopharma Holdings
March 05, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240725635772/en/2183641/22/xeris_BIOPHARMA_TM_L_CMYK_002.jpg)
![](https://mms.businesswire.com/media/20240708688946/en/2178838/22/xeris_BIOPHARMA_TM_L_CMYK.jpg)
Xeris Biopharma Announces CEO Succession Plan
July 08, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240703480900/en/2175482/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240603311134/en/2147784/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20240530612890/en/2145175/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240530275222/en/2143504/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/13/Image32.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240509287355/en/2125539/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/06/stock-chart-1863880-1920-60_0.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240506079856/en/2119832/5/Beta_Bionics_Logo_-_2Color.jpg)
![](https://mms.businesswire.com/media/20240502061352/en/2110350/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240403328919/en/2086848/22/xeris_BIOPHARMA_TM_L_CMYK_002.jpg)
![](https://mms.businesswire.com/media/20240402611352/en/2085318/22/xeris_BIOPHARMA_TM_L.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240306129214/en/2055782/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240306343645/en/2055767/22/xeris_BIOPHARMA_TM_L_CMYK_002.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240228184972/en/2046125/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240205852546/en/2021290/22/xeris_BIOPHARMA_TM_L.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/10/image_4.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.